COVID-19: Up to 82% critically ill patients had low Vitamin C values

Teresa Maria Tomasa-Irriguible; Lara Bielsa-Berrocal

doi:10.1186/s12937-021-00727-z

COVID-19: Up to 82% critically ill patients had low Vitamin C values

Nutr J. 2021 Jul 9;20(1):66. doi: 10.1186/s12937-021-00727-z.

Authors

Teresa Maria Tomasa-Irriguible¹, Lara Bielsa-Berrocal²

Affiliations

¹ Intensive Care Department, Germ, ans Trias I Pujol Hospital, Germans Trias I Pujol University Hospital, Autónoma de Barcelona University, Carretera del Canyet s/n, 08916, Badalona, , Barcelona, Spain. teresatomasa@gmail.com.
² Intensive Care Department, Germ, ans Trias I Pujol Hospital, Germans Trias I Pujol University Hospital, Autónoma de Barcelona University, Carretera del Canyet s/n, 08916, Badalona, , Barcelona, Spain.

Abstract

There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.

Keywords: ARDS; COVID-19; Critically ill patient; Epidemiology; ICU; SARS-CoV-2; Vitamin C.

Publication types

Observational Study

MeSH terms

Adult
Aged
Ascorbic Acid / blood*
COVID-19 / blood*
Critical Illness
Female
Humans
Male
Middle Aged
SARS-CoV-2
Vitamins / blood

Substances

Vitamins
Ascorbic Acid